Benchmark Reiterates Buy on ICU Medical Following Management Meetings
March 18, 2013 at 08:43 AM EDT
In a report published Monday, Benchmark Company analyst James Terwilliger reiterated a Buy rating and $69.00 price target on ICU Medical (NASDAQ: ICUI ). In the report, Terwilliger noted, “We were recently marketing with a member of the ICU Medical management team, and we remain comfortable with our 2013 revenue